Exabis Library
Welcome to the e-CCO Library!
P541: Efficacy, efficiency and aceptability of telemedicine for inflammatory bowel disease patients follow-up care during the COVID-19 pandemic lockdown.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P541: Intestinal failure: a rare but significant outcome of restorative proctocolectomy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P541: Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P542 The effect of age on infliximab pharmacokinetics in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P542: Clinical presentation, disease behavior and management of inflammatory bowel disease at extremes of age
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P542: Efficacy and safety of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P542: Infliximab salvage therapy in acute severe ulcerative colitis: A systematic review and meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P542: Long-term outcomes after switching from originator infliximab to biosimilar in paediatric-onset inflammatory bowel disease patients: a single centre prospective observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P542: Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P542: Topical tacrolimus versus systemic biological therapy for refractory ulcerative proctitis: a retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P543 UC remission mucosa displays upregulated inflammatory mediators
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P543: Higher post-induction infliximab serum trough levels are associated with healing of fistulising perianal Crohn’s disease in children
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P543: Induction and maintenance of mucosal healing in Crohn's disease with ustekinumab in clinical practice – Results of a nationwide, prospective, multicenter study in Germany (MUCUS)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P543: Point-of-care testing in therapeutic drug monitoring of infliximab
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P543: Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P543: Structured transition enhances clinical outcome without an increase in healthcare cost in adolescent patients with IBD: the UK TRANSIT study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P543: The role of social support on psychological distress and health-related quality of life in adults with mild to moderately active Crohn's disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P544 Comparison of the efficacy of a second intravenous or subcutaneous anti-TNF in the treatment of ulcerative colitis: Real-world data from the ENEIDA registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P544: Combination therapy of vedolizumab and a TNF antagonist in IBD patients with severe chronic active, therapy refractory disease course
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P544: Histological remission following ozanimod treatment is associated with concurrent clinical remission and endoscopic mucosal healing: Results from the TOUCHSTONE study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM